Please assess the completion status of the following clinical trial:

Trial Title: Dosage Reduction and Acute Glycemic Complications in People With Type 2 Diabetes Who Fast During Ramadan

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Prospective participant is a returning patient with type 2 diabetes;~* Prospective participant expressed an intention to fast during Ramadan;~* Prospective participant has been compliant with one of four glucose-lowering multidrug regimens for at least the past three months.~Exclusion Criteria:~* Prospective participant is a pregnant, postpartum, breastfeeding, or eumenorrheic woman;~* Prospective participant has experienced diabetic ketoacidosis or hyperosmolar hyperglycemic state within three months;~* Prospective participant has received niacin or corticosteroids within one month; and,~* Prospective participant has any history of recurrent hypoglycemia, hypoglycemia unawareness, chronic renal insufficiency (stages IV or V), liver cirrhosis, uncontrolled epilepsy, depressive disorder, bipolar disorder, psychotic disorder, or cognitive dysfunction.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Low-dosage therapy (Type: EXPERIMENTAL): None
- Regular-dosage therapy (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).